Food and Drug Regulation

Policymakers should account for the relatively low risks of psychedelics use when deciding how to regulate them.

Experts discuss the benefits and drawbacks of existing regulatory frameworks for psychedelics.

The convergence of current psychedelics regulatory pathways may bring benefits and new challenges.

Scholars urge Congress to give FDA more power to regulate dietary supplements.

Scholars analyze FDA’s emergency use authorizations during the COVID-19 pandemic.

Scholars critique the scarcity of regulation surrounding food marketing to children.

Scholar analyzes the relation between federal regulation and assisted death initiatives.

Experts debate the role of pharmacy benefit managers in rising U.S. drug prices.

Scholars propose avenues to improving the regulation of clean food labels.

Patents covering drugs selected for Medicare price negotiation show how patents influence drug prices.

Scholar argues that FDA should be the sole regulator of cell-cultured meat.

FDA approves first over-the-counter treatment to combat the opioid overdose epidemic.